135 related articles for article (PubMed ID: 4256760)
1. 3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
Gordon EK; Oliver J
Clin Chim Acta; 1971 Nov; 35(1):145-50. PubMed ID: 4256760
[No Abstract] [Full Text] [Related]
2. Cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-dopa.
Wilk S; Mones R
J Neurochem; 1971 Sep; 18(9):1771-3. PubMed ID: 5571114
[No Abstract] [Full Text] [Related]
3. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Chase TN; Gordon EK; Ng LK
J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
[No Abstract] [Full Text] [Related]
4. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
Johansson B; Roos BE
Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
[No Abstract] [Full Text] [Related]
5. Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
Mena MA; Aguado EG; de Yebenes JG
Acta Neurol Scand; 1984 Apr; 69(4):218-25. PubMed ID: 6204498
[TBL] [Abstract][Full Text] [Related]
6. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
[No Abstract] [Full Text] [Related]
7. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
van Woert MH; Bowers MB
Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
[No Abstract] [Full Text] [Related]
8. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
Korf J; van Praag HM; Sebens JB
Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
[No Abstract] [Full Text] [Related]
9. Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid.
Gordon EK; Oliver J; Goodwin FK; Chase TN; Post RM
Neuropharmacology; 1973 Apr; 12(4):391-6. PubMed ID: 4703880
[No Abstract] [Full Text] [Related]
10. Central monoamine metabolism in Parkinson's disease.
Chase TN; Ng LK
Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
[No Abstract] [Full Text] [Related]
11. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
Post RM; Goodwin FK
Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
[No Abstract] [Full Text] [Related]
12. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
Garelis E; Young SN; Lal S; Sourkes TL
Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
[No Abstract] [Full Text] [Related]
13. Separation and identification of neutral and acidic metabolites in cerebrospinal fluid.
Waterbury LD; Pearce LA
Clin Chem; 1972 Mar; 18(3):258-62. PubMed ID: 5020821
[No Abstract] [Full Text] [Related]
14. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
15. Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease.
Lakke JP; Korf J; Van Praag HM; Schut T
Nat New Biol; 1972 Apr; 236(68):208-9. PubMed ID: 4553111
[No Abstract] [Full Text] [Related]
16. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
Rinne UK; Sonninen V
Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
[No Abstract] [Full Text] [Related]
17. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
Olsson R; Roos BE
Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
[No Abstract] [Full Text] [Related]
18. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Chase RN; Schnur JA; Brody JA; Gordon EK
Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
[No Abstract] [Full Text] [Related]
19. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline.
Bowers MB
Psychopharmacologia; 1972; 23(1):26-33. PubMed ID: 5018977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
